Derive vs Injective

Compare Derive and Injective on TVL, fees, revenue and activity to understand how these projects stack up.

$179.82M
Derive V3 Options is the options market of Derive V3, the latest version of the self-custodial derivatives exchange formerly known as Lyra. V3 runs on a zkVM exchange that settles trades on Ethereum: orders are matched on a central limit order book while positions, margin and settlement stay verifiable on-chain. Traders can buy and sell European options on major crypto assets with portfolio margin shared across options, perpetuals and spot, and market makers quote directly into the book.
View Full Page
Injective Perps is the perpetual futures market of Injective, a layer 1 blockchain optimized for finance. Trading runs on Injective's native onchain order book module, which offers fully onchain matching and settlement, front-running resistance through frequent batch auctions and very low fees. Markets cover major crypto assets as well as real-world assets such as equities, commodities and forex, and the shared liquidity layer is used by multiple trading front-ends built on Injective. Part of the fees feeds the INJ burn auction.
View Full Page

Key Metrics Comparison

Derive
TVL
$179.82M
24h Volume
$7.8K
24h Fees
$13.1K
24h Revenue
$9.9K
30d Fees
$560.3K
30d Revenue
$453.9K
7d TVL Change
-3.67%
Dominance
0.20%
Injective
TVL
N/A
24h Volume
$4.43M
24h Fees
N/A
24h Revenue
N/A
30d Fees
N/A
30d Revenue
N/A
7d TVL Change
N/A
Dominance
0.00%

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

TVL Share

Share of combined TVL

TVL Share
Derive
1.0%
Injective
1.0%

Volume Share

Share of combined 24h volume

Volume Share
Derive
1.0%
Injective
99.8%

Fees Share

Share of combined 24h fees

Fees Share
Derive
1.0%
Injective
1.0%

Revenue Share

Share of combined 24h revenue

Revenue Share
Derive
1.0%
Injective
1.0%

7d TVL Performance

TVL change over last 7 days

7d TVL Performance
Derive
-3.67%
Injective
N/A

Dominance

Market dominance by TVL

Dominance
Derive
0.2%
Injective
0.0%